The
enzyme 3-mercaptopyruvate sulfurtransferase (3-MST) is one
of the more recently identified mammalian sources of H2S. A recent study identified several novel 3-MST inhibitors with
micromolar potency. Among those, (2-[(4-hydroxy-6-methylpyrimidin-2-yl)sulfanyl]-1-(naphthalen-1-yl)ethan-1-one)
or HMPSNE was found to be the most potent and selective. We now took
the central core of this compound and modified the pyrimidone and
the arylketone sides independently. A 63-compound library was synthesized;
compounds were tested for H2S generation from recombinant
3-MST in vitro. Active compounds were subsequently tested to elucidate
their potency and selectivity. Computer modeling studies have delineated
some of the key structural features necessary for binding to the 3-MST’s
active site. Six novel 3-MST inhibitors were tested in cell-based
assays: they exerted inhibitory effects in murine MC38 and CT26 colon
cancer cell proliferation; the antiproliferative effect of the compound
with the highest potency and best cell-based activity (1b) was also confirmed on the growth of MC38 tumors in mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.